Sunday, June 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Asian Markets

Almonty Lands a Heavyweight Investor and a New Finance Chief Just as Its Korean Mine Starts to Deliver

Rodolfo Hanigan by Rodolfo Hanigan
May 7, 2026
in Asian Markets, Commodities, Turnaround
0
Almonty Stock
1
SHARES
248
VIEWS
Share on FacebookShare on Twitter

The stars are aligning for Almonty Industries. The tungsten developer has secured a marquee institutional backer, recruited a new chief financial officer with a track record of doubling market caps, and is on the cusp of generating first revenue from its flagship Sangdong mine in South Korea — all within a matter of weeks.

Fidelity, the global asset management behemoth, has taken a 6.5% stake in the company, acquiring 18.28 million shares. The filing with US regulators marks one of the most significant votes of confidence yet in Almonty’s pivot from a development-stage miner to a producing supplier of non-Chinese tungsten. The timing is no coincidence: China’s export restrictions on strategic metals have sent tungsten prices into orbit. Ammonium paratungstate (APT) has surged roughly 230% since the end of 2025, with a metric ton now fetching around $3,000.

A New CFO for the Next Chapter

Effective June 1, Jorge Beristain will take over as chief financial officer, replacing Brian Fox, who has left the company. Guillaume de Lamaziere, currently chief development officer, will serve as interim finance chief until Beristain’s arrival. The appointment is a deliberate move for a company on the verge of a transformation.

Beristain brings a rare combination of skills. At Ryerson Holding Corp, a company with roughly $5 billion in annual revenue, he served as vice president of finance and helped double the market capitalization. Before that, he led metals and mining equity research for the Americas as a managing director at Deutsche Bank Securities. CEO Lewis Black described Beristain as the right executive to guide Almonty through its next growth phase — bringing Sangdong into production and positioning the company as a Western alternative to Chinese tungsten suppliers.

Sangdong’s Countdown to Cash Flow

The Sangdong mine completed its first commissioning phase in March and is now ramping up output. Management expects the operation to generate meaningful revenue in 2026, marking Almonty’s transition from a pure developer to a cash-flow-generating producer. That shift is already being priced into the stock.

For the 2025 fiscal year, Almonty posted revenue of $32.5 million, up 13% year-over-year, though it recorded a net loss of $161.9 million. The company’s market capitalization currently stands at roughly $5.7 billion.

Should investors sell immediately? Or is it worth buying Almonty?

A Stock on a Tear

The market has been rewarding the strategic pivot. Almonty’s shares have surged about 142% since the start of the year — or roughly 139% depending on the pricing point — and have more than 700% over the past twelve months. The stock closed recently at C$29.13, about 11% above its 50-day moving average but still roughly 9% below its 52-week high of C$32.07. After the Fidelity news, the shares ticked up to C$28.77.

Analysts remain broadly bullish. The consensus among seven analysts is a “Strong Buy” rating, with an average price target of C$23.71 and a high estimate of C$36.00. The fact that the current share price already exceeds the consensus target underscores how much of Sangdong’s potential has been baked into the valuation. Some discounted cash flow models peg the fair value as high as C$44.

Pentagon Pivot and a New Home Base

Almonty is also repositioning itself geographically and strategically. In mid-April, the company moved its corporate headquarters from Toronto, Canada, to Dillon, Montana. The relocation is aimed squarely at winning contracts from the US defense industry, which is desperate for secure, non-Chinese tungsten supplies. The acquisition of the Gentung tungsten project in Montana reinforces that push into North American government circles.

What’s Next

On June 9, management will host the annual general meeting in Toronto. Shareholders will vote on the election of a seven-member board and approve the previous year’s financial statements. But the real focus will be on operational updates — specifically, how the ramp-up at Sangdong is progressing and what the second expansion phase looks like.

With Fidelity’s stamp of approval, a seasoned CFO arriving just as production begins, and a tungsten market in the grip of a supply crisis, Almonty has three concrete catalysts lined up for the second half of 2026. Whether the stock can hold its lofty valuation will depend on how smoothly the Sangdong ramp-up unfolds.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from June 14 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 14.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Uranium Energy Stock
Analysis

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
European Lithium Stock
Commodities

European Lithium Faces a Trio of Hurdles as Lithium Markets Show Signs of Turning

June 14, 2026
Green Bridge Metals Stock
Commodities

Green Bridge Metals: Historic Policy Support Can’t Halt the Slide as Minnesota Drilling Awaits Answers

June 13, 2026
Next Post
CSG Stock

CSG Systems Posts Blowout Q1 Earnings Even as NEC Takeover Looms

Microsoft Stock

Xbox Chief Axes Copilot Plans as Microsoft Pivots From Gaming to Grid-Scale AI

Retail Investors Storm the Private Markets While the DAX Stalls at 25,000

Retail Investors Storm the Private Markets While the DAX Stalls at 25,000

Recommended

Novo Nordisk Stock

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

5 months ago
Blackrock Stock

BlackRock’s Global Strategy: Dividend Payouts and Market Expansion

9 months ago
D-Wave Quantum Stock

D-Wave Quantum: A Story of High Ambition Amidst Financial Crosscurrents

3 months ago
Ooma Stock

Ooma Stock: A Clash Between Analyst Optimism and Insider Selling

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

OHB’s Record Backlog and a Shifting Shareholder Base Set the Stage for a Defining Summer

Germany’s Communities Feel the Squeeze as Labour Shortage Forecast Worsens by 1.3 Million

European Lithium Faces a Trio of Hurdles as Lithium Markets Show Signs of Turning

OHB’s Free Float Squeeze Nears a Release as KKR Exit and Rocket Flight Converge

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

by Rodolfo Hanigan
June 14, 2026
0

The Danish pharmaceutical heavyweight arrived at the American Diabetes Association congress in New Orleans armed with a...

BMW Stock

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Ocugen Stock

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

June 14, 2026
Amazon Stock

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

June 14, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape
  • BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans
  • Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com